Low concentrations of ouabain increase cytosolic free calcium concentration in rat vascular smooth muscle cells

Clinical Science

Volumn 90, Issue 1, 1996, Pages 9-12

  Zhu, Zhiming ^a   Tepel, Martin ^a   Neusser, Marcus ^a   Zidek, Walter ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Calcium; Ouabain; Vascular smooth muscle

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; NIFEDIPINE; OUABAIN; SODIUM ION; THAPSIGARGIN;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030053793     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900009     Document Type: Article

References (25)

1. +-ATPase inhibitors in hypertension. Hypertension 1991; 17: 830-6.
2. Smith TW. Digitalis. Mechanism of action and clinical use. N Engl J Med 1988; 318: 358-65.
3. Woolfson RG, Hilton PJ, Poston L. Effects of ouabain and low sodium on contractility of human resistance arteries. Hypertension 1990; 15: 583-90.
4. Yuan CM, Manunta P, Hamlyn JM, et al. Long-term ouabain administration produces hypertension in rats. Hypertension 1993; 22: 178-87.
5. 2+ stores and cell responsiveness. Am J Physiol 1993; 264: C1367-87.
6. Harris DW, Clark MA, Fisher JF, et al. Development of an immunoassay for endogenous digitalis-like factor. Hypertension 1991; 17: 936-43.
7. Gottlieb SS, Rogowski AS, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992; 86: 420-5.
8. Lewis LK, Yandle TG, Lewis JG, et al. Ouabain is not detectable in human plasma. Hypertension 1994; 24: 549-55.
9. Weiss DN, Podberesky DJ, Heidrich J, Blaustein MP. Nanomolar ouabain augments caffeine-evoked contractions in rat arteries. Am J Physiol 1993; 265: C1443-8.
10. 2+ influx by a tyrosine kinase-dependent pathway. J Biol Chem 1994; 269: 26239-42.
11. Zhu Z, Neusser M, Tepel M, Spieker C, Golinski P, Zidek W. Effect of Na,K-ATPase inhibition on cytosolic free calcium ions in vascular smooth muscle cells of spontaneously hypertensive and normotensive rats. J Hypertens 1994; 12: 1007-12.
12. Bendhack LM, Sharma RV, Bhalla RC. Altered signal transduction in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension 1992; 19: 1142-8.
13. Exton JH. Calcium signalling in cells: molecular mechanisms. Kidney Int 1987; 32: 68-76.
14. 2+ distribution in vascular smooth muscle cells of spontaneously hypertensive rats. J Vasc Res 1993; 30: 116-20.
15. 2+ regulation in aortic vascular smooth muscle cells. Am J Physiol 1991; 261: C845-56.
16. 2+ in vascular smooth muscle cells. Am J Physiol 1994; 266: C794-9.
17. Toda N, Mechanism of ouabain-induced arterial smooth muscle contraction. Am J Physiol 1980; 239: H199-205.
18. Moromizato H, Miyagi H, Nakayama M, Higuchi M, Sakanashi M. Effects of ouabain on contractile response to norepinephrine in isolated rat aorta. Gen Pharmacol 1992; 23: 279-83.
19. Hamlyn JM, Ashen MD, Forrest B, Rogowski AC, White RJ. Species sensitivity of the sodium pump to a circulating ouabain-like inhibitor in acute hypervolaemia and DOCA hypertension: comparison with ouabain. Prog Biochem Pharmacol 1988; 23: 22-34.
20. +-ATPase. Biochim Biophys Acta 1990; 1027: 1-7.
21. 2+ and cell responsiveness. Am J Physiol 1993; 264: C1367-87.
22. +-adenosine triphosphatase on vascular action of vasopressin. J Clin Invest 1990; 86: 1241-8.
23. Zhu Z, Tepel M, Neusser M, Zidek W. Transforming growth factor β1 modulates angiotensin II-induced calcium influx in vascular smooth muscle. Eur J Clin Invest 1995; 25: 317-21.
24. +-ATPase-1 subunit isoform, J Biol Chem 1991; 266: 18308-12.
25. +)-ATPase isozymes for cardioactive steroids, role of lactone ring, sugar moiety and KCl concentration. Biochem Pharmacol 1990; 40: 2611-16.